Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
JP Stock MarketDetailed Quotes
4598 Delta-Fly Pharma
- 468
- -22-4.49%
20min DelayMarket Closed Apr 28 15:30 JST
4.55BMarket Cap-2.35P/E (Static)
495High468Low201.60KVolume487Open490Pre Close96.34MTurnover76552wk High2.59%Turnover Ratio9.73MShares40352wk Low-218.3EPS TTM3.65BFloat Cap5380Historical HighLossP/E (Static)7.80MShs Float403Historical Low-198.78EPS LYR5.51%Amplitude--Dividend TTM13.36P/B100Lot Size--Div YieldTTM
Delta-Fly Pharma News
Delta-Fly Pharma: change report
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: Explanatory materials on the issuance of the 10th Stock Acquisition Rights and Unsecured Corporate Bonds (Private Placement Bonds) with Exercise Price Amendment Clauses through Third-Party Allotment
Delta-Fly Pharma: Notice Concerning Issuance of the 10th Stock Acquisition Rights and Unsecured Corporate Bonds (Private Placement Bonds) with Exercise Price Amendment Clauses through Third-Party Allotment
Delta-Fly Pharma: Securities registration form (embedded method)
Delta-Fly Pharma: Announcement of novel patent filing for the DFP-10917 drug product
Delta-Fly Pharma: Notice regarding the new patent application for DFP-10917
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: Announcement for a phase 2/3 study of DFP-17729 to be started
Delta-Fly Pharma: Notice regarding the commencement of clinical phase 2/3 comparative trials of DFP-17729
Delta-Fly Pharma: Notice regarding clinical trial status of DFP-10917+VEN
Delta-Fly Pharma: 3Q financial results presentation materials for the fiscal year ending 2025/3 20250214
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: Change Report (Special Case Target Stock Certificates, etc.)
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: 2025 President's New Year's Greetings (Notice regarding progress of major development products)
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: Large holding reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: change report
Delta-Fly Pharma: Notice regarding completion of exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses) and monthly exercise status
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts